Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study-Reference-Cited by-同舟云学术

Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study

Published:2017-06 Issue:29 Volume:35 Page:3647-3654
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

LeBlanc Jason J.^ORCID,ElSherif May,Ye Lingyun,MacKinnon-Cameron Donna,Li Li,Ambrose Ardith,Hatchette Todd F.,Lang Amanda L.,Gillis Hayley,Martin Irene,Andrew Melissa K.,Boivin Guy,Bowie William,Green Karen,Johnstone Jennie,Loeb Mark,McCarthy Anne,McGeer Allison,Moraca Sanela,Semret Makeda,Stiver Grant,Trottier Sylvie,Valiquette Louis,Webster Duncan,McNeil Shelly A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference32 articles.

1. A retrospective study of the clinical burden of hospitalized all-cause and pneumococcal pneumonia in Canada;McNeil;Can Respir J,2015

2. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults;Jain;N Engl J Med,2015

3. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates;O'Brien;Lancet,2009

4. Pneumococcal infection in adults: burden of disease;Drijkoningen;Clin Microbiol Infect,2014

5. A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults;Chalmers;BMC Pulm Med,2016

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine–Experienced Adults 50 Years of Age or Older (STRIDE-6);Clinical Infectious Diseases;2024-07-31

2. Mucosal adjuvanticity and mucosal booster effect of colibactin-depleted probiotic Escherichia coli membrane vesicles;Human Vaccines & Immunotherapeutics;2024-04-24

3. Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness;Open Forum Infectious Diseases;2023-06-13

4. Invasive Pneumococcal Disease Characterization in Adults and Subgroups aged < 60 years and ≥ 60 years in Bogota, Colombia;IJID Regions;2022-06

5. Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay;Vaccine;2022-04